 |
|
 |
 |

Home > Company Index > Drugs > Biotechnology-Medicine > Vysis, Inc.
 |
Vysis, Inc. |
 |
 |
 |
NEWS FROM THE WIRES |
 |
Vysis posts Q2 profit vs year-ago loss Aug 14 2001 07:22 AM PDT
Vysis files to sell 3 mln shares on behalf of BP Aug 07 2001 02:21 PM PDT
Vysis says FDA approves bladder cancer test Aug 02 2001 05:53 AM PDT
> More WIRE STORIES about this company
PROFILE |
 |
Vysis makes genetic testing products for cancer, prenatal disorders, and other diseases. A subsidiary of oil giant BP (formerly BP Amoco), it sells diagnostics for leukemia and amniocentesis kits to detect Down Syndrome and other genetic birth defects. It is developing diagnostics for breast, bladder, lung, and cervical cancers. The firm's products are sold in almost 60 countries; the US accounts for more than half of sales. Vysis has collaborative agreements with such institutions as the Mayo Clinic, Eos Biotechnology, and the University of California. Subsidiary Gene-Trak Systems Industrial Diagnostics makes DNA-based food testing kits to food processors and quality control labs. BP owns 65% of Vysis.
COMPETITION |
 |
Applied Imaging Corp. (AICX)
Ventana Medical Systems, Inc. (VMSI)
|
 |
STOCK ANALYSIS |
 |
FURTHER ANALYSIS
Advanced Charting
Deals
FINANCIAL OVERVIEW |
 |
Fiscal Year-End: December
2000 Sales (mil.): 24.00
1-Yr. Sales Growth: 10.6%
Employees: 133
Revenue per employee: $180,451.13
KEY PEOPLE |
 |
John L. Bishop
CEO
John R. Sluis
CFO
CONTACT INFO |
 |
3100 Woodcreek Dr.
Downers Grove, IL 60515
US
Phone: 630-271-7000
Fax: 630-271-7138
Online: Web Site
|
 |
 |
 |
|
Hoover's Company Capsule
Copyright © 2001, Hoover's Inc. Austin, Texas.
For changes and updates, contact Hoover's directly.
|

|
 |
 |
|
 |